Jessica L. Taylor, MD
Assistant Professor
Boston University Chobanian & Avedisian School of Medicine
Medicine
General Internal Medicine

MD, Mount Sinai School of Medicine
BS, Duke University

Pronouns: she/her/hers



Jessica L. Taylor, MD is an Assistant Professor of Medicine in General Internal Medicine at the Chobanian and Avedisian School of Medicine and Boston Medical Center and a board-certified Addiction Specialist. She attended Mount Sinai School of Medicine and completed internal medicine residency training at Beth Israel Deaconess Medical Center and Harvard Medical School, where she also served as a Chief Resident. Dr. Taylor’s clinical work focuses on the care of patients with substance use disorders, HIV, and viral hepatitis.

Her research interests include HIV prevention among people who inject drugs, HIV pre-exposure prophylaxis (PrEP) implementation, low-barrier substance use disorder treatment models, and overdose prevention. She is Co-Director of the Care Continuum Core for the Massachusetts site of the NIDA-funded Healing Communities Study, which aims to reduce fatal opioid overdose by 40%.

Dr. Taylor is the Medical Director of Faster Paths to Treatment, Boston Medical Center’s innovative, low-barrier substance use disorder bridge clinic and the Medical Director of the Transitional Care Clinic, a bridge clinic co-located with a low-threshold, transitional housing program for people experiencing homelessness. She directs HIV Prevention Programs at BMC. Her educational roles include directing the HIV Pathway for internal medicine residents and serving as core faculty in BUSM’s Addiction Medicine fellowship program.

Faculty
Boston University Chobanian & Avedisian School of Medicine
Medicine
Clinical Addiction Research and Education Unit




Statewide Technical Assistance Support Services for Hospital-based SUD Programs
08/01/2024 - 06/30/2025 (PI)
Massachusetts Dept. of Public Health / DPH


Hospital Based SUD Services
05/01/2024 - 06/30/2025 (PI)
Massachusetts Dept. of Public Health / DPH

Massachusetts HIV and Justice-Involved Populations Research Network
05/15/2024 - 09/30/2024 (Subcontract PI)
PI: Jessica L. Taylor, MD
Tufts Medical Center NIH NIDA


Faster Paths to Treatment
04/01/2016 - 06/30/2024 (PI)
Massachusetts Dept. of Public Health / DPH


Population-Level Effects of Increasing PrEP Uptake on HIV and Bacterial STIs
07/26/2019 - 06/30/2021 (PI)
Harvard Pilgrim Health Care (HPHC) NIH-NIAID
1R21AI143386-01A1

Population-Level Effects of Increasing PrEP Uptake on HIV and Bacterial STIs
07/26/2019 - 06/30/2020 (Subcontract PI)
PI: Jessica L. Taylor, MD
Harvard Pilgrim Health Care / HPHC NIH NIAID
5R21AI143386-02


Title


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Website       Copy PMIDs To Clipboard

  1. Chatterjee A, Chase RP, Chahine RA, Davis J, Dsouza N, Ellison S, Bagley SM, Fisher T, Glasgow L, Harris MTH, Huang TT, Holloway J, Lounsbury DW, Oga E, Asman K, Roberts SM, Sabounchi N, Surratt HL, Lines LM, Stadler HW, Taylor JL, Davis A. Local level of social inequity moderates implementation of evidence-based practices tailored to minoritized populations to reduce opioid overdose deaths. J Subst Use Addict Treat. 2026 Jan; 180:209828.View Related Profiles. PMID: 41175975; DOI: 10.1016/j.josat.2025.209828;
     
  2. Brown JL, Larochelle MR, Fanucchi LC, Calvert DC, Campbell ANC, Chandler RK, Feaster DJ, Glasgow LM, Gibson EB, Holloway J, Lofwall MR, Mack A, Mack N, Nunes EV, Talbert JC, Tan S, Vandergrift N, Villani J, Asman K, Babakhanlou-Chase H, Bagley SM, Battaglia TA, Blevins D, Bridden C, Cheng DM, Christopher M, Cogan LW, Cunningham CO, Eggleston B, Fareed N, Fernandez S, Freedman DA, Freiermuth CE, Freisthler B, Gilbert L, Hammerslag L, Harris D, Hunt T, Hussain S, Huynh P, Jackson RD, Kauffman EB, Knott C, Knudsen HK, Lefebvre RC, Levin FR, Massatti R, McAlearney AS, Morgan JR, Lopez RM, Lounsbury DW, Newman L, Nickels K, Oga EA, Oller DA, Parran TV, Quinn M, Ramsey KS, Rapkin BD, Salsberry P, Stein M, Taylor JL, Teater J, Walters ST, Zarkin GA, El-Bassel N, Winhusen TJ, Samet JH, Walsh SL. Effects of the Communities That HEAL intervention on initiation, retention, and linkage to medications for opioid use disorder (MOUD): A cluster randomized wait-list controlled trial. Drug Alcohol Depend. 2025 Sep 01; 274:112785.View Related Profiles. PMID: 40684522; PMCID: PMC12302724; DOI: 10.1016/j.drugalcdep.2025.112785;
     
  3. Palfai TP, Kratzer MPL, Taylor JL, Otis JD, Winter MR. Addressing Pain and Heavy Drinking among Patients in HIV-Care: A Pilot Study of an Integrated Telehealth Intervention. AIDS Behav. 2025 Jun; 29(6):1930-1943.View Related Profiles. PMID: 39998790
     
  4. Libman H, Krakower D, Taylor JL, Burns RB. How Would You Manage HIV Pre-exposure Prophylaxis in This Patient With Medical Comorbidities? Ann Intern Med. 2024 Dec; 177(12):1743. PMID: 39680948; DOI: 10.7326/ANNALS-24-02555;
     
  5. Li C, Burke MM, Taylor JL, DaWalt LS, Rossetti Z. Establishing an Advocacy Activities Scale for Parents of Individuals With Intellectual and Developmental Disabilities. Intellect Dev Disabil. 2024 Dec 01; 62(6):486-499. PMID: 39581212; DOI: 10.1352/1934-9556-62.6.486;
     
  6. De La Hoz A, Pooja A, Kancharla A, Schechter-Perkins EM, Ruiz-Mercado G, Baldwin M, Nunes D, Taylor JL. Characteristics and Outcomes of Direct-Acting Antiviral Experienced Patients with Hepatitis C Undergoing Retreatment at an Essential Hospital in the United States. Open Forum Infect Dis. 2024 Dec; 11(12):ofae704.View Related Profiles. PMID: 39703790; PMCID: PMC11656337; DOI: 10.1093/ofid/ofae704;
     
  7. Rozansky H, Christine PJ, Younkin M, Fox JM, Weinstein ZM, Suarez S, Stewart J, Farrell N, Taylor JL. Addiction consult service involvement in PrEP and PEP delivery for patients who inject drugs admitted to an urban essential hospital. Addict Sci Clin Pract. 2024 Nov 04; 19(1):77.View Related Profiles. PMID: 39497126; PMCID: PMC11533369; DOI: 10.1186/s13722-024-00502-5;
     
  8. De La Hoz A, Gadi N, Lopez CG, Barrera-Godinez A, Miller NS, Bourque DL, Brem C, Ozluk E, Seth G, Kimball S, Taylor JL. Immune Reconstitution Inflammatory Syndrome in a Patient With Cutaneous Leishmaniasis and HIV: A Diagnostic Challenge for Clinicians Caring for a Migrant Population in the United States. Open Forum Infect Dis. 2024 Oct; 11(10):ofae587.View Related Profiles. PMID: 39474451; PMCID: PMC11518855; DOI: 10.1093/ofid/ofae587;
     
  9. Freisthler B, Chahine RA, Villani J, Chandler R, Feaster DJ, Slavova S, Defiore-Hyrmer J, Walley AY, Kosakowski S, Aldridge A, Barbosa C, Bhatta S, Brancato C, Bridden C, Christopher M, Clarke T, David J, D'Costa L, Ewing I, Fernandez S, Gibson E, Gilbert L, Hall ME, Hargrove S, Hunt T, Kinnard EN, Larochelle L, Macoubray A, Nigam S, Nunes EV, Oser CB, Pagnano S, Rock P, Salsberry P, Shadwick A, Stopka TJ, Tan S, Taylor JL, Westgate PM, Wu E, Zarkin GA, Walsh SL, El-Bassel N, Winhusen TJ, Samet JH, Oga EA. Communities That HEAL Intervention and Mortality Including Polysubstance Overdose Deaths: A Randomized Clinical Trial. JAMA Netw Open. 2024 Oct 01; 7(10):e2440006.View Related Profiles. PMID: 39432308; PMCID: PMC11581668; DOI: 10.1001/jamanetworkopen.2024.40006;
     
  10. Braun HM, Taylor JL, Axelrath S. Buprenorphine/naloxone - one formulation that doesn't fit all: a case report. Harm Reduct J. 2024 Jul 30; 21(1):143. PMID: 39080714; PMCID: PMC11287853; DOI: 10.1186/s12954-024-01054-2;
     
Showing 10 of 56 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 56 publications over 10 distinct years, with a maximum of 18 publications in 2024

YearPublications
20081
20151
20182
20192
20205
20219
20228
20237
202418
20253

Note: X.com has changed/limited the ability to embed tweets directly in external sites and we are investigating ways to restore that functionality in BU Profiles. In the meantime we are displaying a link to your x.com profile in the Websites section above.

Let doctors prescribe methadone

The Boston Globe 11/9/2023

‘Tranq,’ used in a deadly drug combo, threatens Massachusetts users

The Boston Globe 4/12/2023

Methadone doses haven’t kept up in the age of fentanyl. A new rule aims to help

STAT 3/21/2023

Boston warns of increase in overdoses due to cocaine contaminated with fentanyl

Boston Globe 2/23/2023

Animal tranquilizer increasingly showing up in New England street drugs

WGBH News 2/15/2023

'We’re not out of the woods’: Opioid-related deaths declined this year, but just slightly

The Boston Globe 12/14/2022

Drug overdose deaths have increased 15% to nearly 108,000

Boston Herald 5/12/2022

BMC Bridge Clinic Charts a Needed Path to Methadone for Opioid Withdrawal

HealthCity 2/23/2022

Report: 2020 record year for fatal Mass. opioid overdoses

Boston 25 News 5/12/2021

Drug Use by State: 2021’s Problem Areas

WalletHub 5/11/2021

CDC report finds big jump in pandemic drug overdose deaths

Boston 25 News 4/15/2021

US drug overdose deaths surged during COVID-19 lockdowns

LiceScience 4/15/2021

COVID-19's "Alarming" Effect on HIV Outbreaks Among People Who Inject Drugs

HealthCity 2/10/2021

These Key Telehealth Policy Changes Would Improve Buprenorphine Access While Advancing Health Equity

Health Affairs Blog 9/11/2020

Opioid Crisis Continues Amid Pandemic: Some Concerned Isolation Could Lead to More Overdoses

PIX 11 4/20/2020

Social Distancing May Increase HIV and Overdose Risk for At-Risk Populations

HealthCity 4/13/2020

Relaxed Federal Policies Enable Street Outreach for Substance Use Treatment During COVID-19

HealthCity 4/13/2020

COVID-19 Adds to Challenges of Treating Deadly Addictions

Modern Healthcare 4/10/2020

Coronavirus Pandemic Complicates Opioid Treatment

The Wall Street Journal 4/7/2020

A Scramble to Continue Care for People With Addiction Amid Deep Fears for the Most Vulnerable

The Boston Globe 4/3/2020
In addition to these self-described keywords below, a list of MeSH based concepts is available here.

HIV
Pre-Exposure Prophylaxis (PrEP)
Substance Use Disorders
Hepatitis C viruses
Sexually Transmitted Infections
Overdose, Drug

Dr. Taylor has mentored medical students in the summer research program. She also mentors residents and fellows on education, QI, and original research projects related to substance use disorders, HIV prevention, HIV pre-exposure prophylaxis (PrEP), and sexually transmitted infection testing and treatment, with work leading to multiple regional and national presentations and completed manuscripts. She provides longitudinal clinical mentorship for internal medicine residents interested in HIV primary care, viral hepatitis, PrEP, and substance use disorder treatment.

Available to Mentor as: (Review Mentor Role Definitions):
  • Career Mentor
  • Co-Mentor or Peer Mentor
  • Project Mentor
Contact for Mentoring:
  • Email (see 'Contact Info')

801 Massachusetts Ave Crosstown Center
Boston MA 02118
Google Map

617.414.7399
Download vCard

Taylor's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
See all (151) concept(s)
_
Media Mentions
_
Co-Authors
See all (62) people
_
Similar People
See all (60) people
_
Same Department
Search Department